M. O. Senge et al.
3
7.6 Hz, 2H, Ar H), 7.82 (d, J=7.6 Hz, 4H, Ar H), 7.93 (d, 3J=7.7 Hz,
5,10-Bis(4-methylphenyl)-15,20-bis(4-nitrophenyl)porphyrin (45): By fol-
lowing the general procedure F, compound 29 (30 mg, 0.0462 mmol), 4-ni-
trophenylboronic acid pinacol ester (116 mg, 0.462 mmol), [PdACHTUNGTRENNUNG(PPh3)4]
ꢀ
ꢀ
3
ꢀ
ꢀ
ꢀ
2H, Ar H), 8.22 (d, J=7.6 Hz, 2H, Ar H), 8.59 (s, 2H, Ar H), 8.61 (s,
2H, Hb), 8.73 (d, 3J=4.7 Hz, 2H, Hb), 9.14 (d, 3J=4.7 Hz, 2H, Hb), 9.18
(d, 3J=15.8 Hz, 2H, alkene H), 9.23 ppm (s, 2H, Hb); 13C NMR
ꢀ
(5.3 mg, 0.0046 mmol), and K3PO4 (196 mg, 0.925 mmol) in THF (50 mL)
gave 16 mg (0.021 mmol, 47%) of a purple solid after recrystallization
from CH2Cl2/MeOH. Rf =0.5 (CH2Cl2/n-hexane=1:1, v/v); m.p.>
(150 MHz, CD2Cl2, 258C, TMS): d=21.44, 29.34, 112.65, 120.79, 122.47,
127.78, 129.56, 129.84, 130.91, 132.22, 133.38, 137.61, 138.51, 139.87,
141.39, 142.31, 148.63 ppm; UV/Vis (DMF): lmax (lg e)=444 (4.87), 563
(3.83), 614 nm (3.75).
3008C; 1H NMR (400 MHz, CDCl3, 258C, TMS): d=ꢀ2.76 (s, 2H, NH),
3
2.74 (s, 6H, CH3), 7.60 (d, J=7.6 Hz, 4H, Ar H), 8.11 (d, 3J=7.6 Hz,
ꢀ
4H, Ar H), 8.42 (d, J=8.2 Hz, 4H, Ar H), 8.67 (d, 3J=8.2 Hz, 4H,
3
ꢀ
ꢀ
5,10-Dibromo-15,20-di(n-pentylporphyrin (39): By following the general
procedure C 5,10-diACHTUNGTRENNUNG(n-pentyl)porphyrin (90 mg, 0.2 mmol) and NBS
Ar H), 8.76 (d, 3J=4.7 Hz, 2H, Hb), 8.80 (s, 2H, Hb), 8.92 (s, 2H, Hb),
ꢀ
8.96 ppm (d, 3J=4.7 Hz, 2H, Hb); 13C NMR (125 MHz, CDCl3, 258C,
TMS): d=21.09, 116.47, 121.48, 127.12, 134.66, 137.33, 138.25, 147.31,
148.53 ppm; UV/Vis (DMF): lmax (lg e)=421 (4.90), 516 (3.64), 552
(3.46), 584 (3.34), 655 nm (3.60); HRMS (MS ES+): m/z: calcd for
[C46H32N6O4]: 733.2563 [M+H]+; found 733.2573.
(89 mg, 0.5 mmol) gave 73 mg (0.12 mmol, 60%) of a purple solid after
recrystallization from CH2Cl2/MeOH. Rf =0.62 (CH2Cl2/n-hexane=2:1,
v/v); m.p.>1988C; 1H NMR (400 MHz, CDCl3, 258C, TMS): d=ꢀ3.15
3
(s, 2H, NH), 1.00 (t, J=7.3, 7.0 Hz, 6H, CH2CH2CH2CH2CH3), 1.56 (m,
4H, CH2CH2CH2CH2CH3), 1.77 (m, 4H, CH2CH2CH2CH2CH3), 2.44 (m,
4H,
CH2CH2CH2CH2CH3),
4.77
(t,
3J=7.7,
8 Hz,
4H,
5,10-Bis(4-methylphenyl)-15,20-bis(3-nitrophenyl)porphyrin (46): By fol-
lowing the general procedure F, compound 29 (33 mg, 0.05 mmol), 4-
methoxycarbonylphenyl boronic acid (90 mg, 0.5 mmol), [PdACHTUNGTRENNUNG(PPh3)4]
CH2CH2CH2CH2CH3), 9.20 (m, 4H, Hb), 9.49 ppm (m, 4H, Hb);
13C NMR (150 MHz, 258C, CDCl3): d=13.86, 22.71, 29.40, 32.40, 35.24,
38.25, 101.90, 121.45 ppm; UV/Vis (DMF): lmax (lg e)=422 (4.48), 524
(3.48), 559 (3.25), 605 (2.78), 664 nm (3.14); HRMS (ES+): m/z: calcd
for [C30H33N4Br2]: 607.1072 [M+H]+; found: 607.1097.
(5.8 mg, 0.005 mmol), and K3PO4 (212 mg, 1 mmol) in THF (60 mL) gave
10 mg (0.013 mmol, 30%) of a purple solid after recrystallization from
CH2Cl2/MeOH. Rf =0.3 (CH2Cl2/n-hexane=1:1, v/v); m.p.>3008C;
1H NMR (400 MHz, CDCl3, 258C, TMS): d=ꢀ2.77 (s, 2H, NH), 2.74 (s,
5,10-Bis(4-bromophenyl)porphyrin (41): 4-Bromobenzaldehyde (0.74 g,
4 mmol) was reacted according to
3
3
ꢀ
ꢀ
6H, CH3), 7.60 (d, J=7.6 Hz, 4H, Ar H), 7.99 (t, J=7.6 Hz, 2H, Ar
a
procedure described before.[12]
H), 8.13 (d, J=7 Hz, 2H, Ar H), 8.57 (m, 2H, Ar H), 8.72 (d, 3J=
3
ꢀ
ꢀ
Column chromatography on silica gel (CH2Cl2/n-hexane=1:4, v/v) gave
compound 71 as the first fraction, followed by the title compound and
then traces of (4-bromophenyl)porphyrin. Recrystallization from CH2Cl2/
MeOH gave 46 mg (0.07 mmol, 4%) as purple crystals. Rf =0.38 (CH2Cl2/
n-hexane=1:1, v/v); m.p.>3008C; 1H NMR (500 MHz, CDCl3, 258C,
TMS): d=ꢀ3.45 (brs, 2H, NH), 7.89 (AB, 3J=3J=3J=3J=8.1 Hz, 4H,
8.2 Hz, 4H, Ar H), 8.79 (d, 3J=4.7 Hz, 2H, Hb), 8.93 (s, 2H, Hb), 8.96
ꢀ
(d, 3J=4.7 Hz, 2H, Hb), 9.11 ppm (s, 2H, Hb); 13C NMR (125 MHz,
CDCl3, 258C, TMS): d=29.59, 116.46, 121.52, 122.88, 127.44, 127.66,
128.20, 134.38, 137.61, 138.62, 139.69, 143.64, 146.84 ppm; UV/Vis
(DMF): lmax (lg e)=421 (4.90), 516 (3.64), 551 (3.46), 589 (3.34), 646 nm
(3.16); HRMS (MS ES+): m/z: calcd for [C44H32N4O4]: 733.2563 [M+H]+
; found 733.2540.
3
3
3
3
ꢀ
ꢀ
Ar Hm), 8.05 (AB, J= J= J= J= =8.1 Hz, 4H, Ar Ho), 8.89 (s, 2H,
H
b7,8), 8.96 (AB, 3J=3J=4.7 Hz, 2H, Hb2,13), 9.30 (AB, 3J=3J=4.7 Hz,
5,10-Bis(3-cyanophenyl)-15,20-bis(4-methylphenyl)porphyrin (47): By fol-
lowing the general procedure F, compound 29 (20 mg, 0.0308 mmol), 4-
cyanophenyl boronic acid (46 mg, 0.308 mmol), [PdACTHUNTRGNE(UNG PPh3)4] (3.6 mg,
2H, Hb3,12), 9.38 (s, 2H, Hb17,18), 10.17 ppm (s, 2H, Hmeso); 13C NMR
(63 MHz, CDCl3, 258C, TMS): d=104.53, 118.41, 122.52, 129.90, ~131,
135.89, 140.98 ppm; UV/Vis (CH2Cl2): lmax (lg e)=407 (5.36), 502 (4.33),
0.003 mmol), and K3PO4 (131 mg, 0.617 mmol) in THF (60 mL) gave
534 (3.67), 575 (3.87), 629 nm (3.38); MS (70 eV, EI): m/z (%): 620 (9,
1
10 mg (0.014 mmol, 47%) of the desired product. M.p.>3008C; H NMR
[M]·+), 540 (4, [MꢀBr] ), 464 (3, [MꢀC6H4Br+Br] +), 310 (14, [M]2+);
+
C
ꢀ
(400 MHz, CDCl3, 258C, TMS): d=ꢀ2.79 (s, 2H, NH), 2.74 (s, 6H,
HRMS: m/z: calcd for [C32H20N4Br2]: 618.0055 [M]+; found: 618.0061.
3
ꢀ
ꢀ
CH3), 7.61 (d, J=7 Hz, 4H, Ar H), 7.92 (m, 2H, Ar H), 8.14 (m, 6H,
3
5,10-Bis(4-methoxycarbonylphenyl)-15,20-bis(4-methylphenyl)porphyrin
(43): By following the general procedure F, compound 29 (33 mg,
0.05 mmol), 4-methoxycarbonylphenyl boronic acid (90 mg, 0.5 mmol),
[PdACHTUNGTRENNUNG(PPh3)4] (5.8 mg, 0.005 mmol), and K3PO4 (212 mg, 1 mmol) in THF
(60 mL) gave 20 mg (0.02 mmol, 52%) of a purple solid after recrystalli-
ꢀ
ꢀ
Ar H), 8.49 (t, J=7, 6.4 Hz, 2H, Ar H), 8.55 (m, 2H, Ar-H), 8.74 (d,
3J=4.7 Hz, 2H, Hb), 8.78 (s, 2H, Hb), 8.93 (s, 2H, Hb), 8.96 ppm (d, 3J=
4.7 Hz, 2H, Hb); 13C NMR (150 MHz, CDCl3, 258C, TMS): d=21.10,
110.92, 116.32, 118.48, 121.10, 127.25, 131.16, 134.10, 136.62, 137.26,
137.84, 138.32, 142.99 ppm; UV/Vis (DMF): lmax (log e)=419 (4.88), 514
(3.61), 548 (3.44), 589 (3.31), 646 nm (3.38); HRMS (MS ES+): m/z:
calcd for [C48H32N6]: 693.2767 [M+H]+; found 693.2743.
zation from CH2Cl2/MeOH. Rf =0.28 (CH2Cl2/n-hexane=1:1, v/v); m.p.>
3008C; 1H NMR (400 MHz, CDCl3, 258C, TMS): d=ꢀ2.76 (s, 2H, NH),
3
ꢀ
2.70 (s, 6H, CH3), 4.13 (s, 6H, OCH3), 7.59 (d, J=7.6 Hz, 4H, Ar H),
5,10-Bis(4-methoxycarbonylphenyl)-15,20-diphenylporphyrin (48): By fol-
lowing the general procedure F, compound 36 (30 mg, 0.048 mmol), 4-
methoxycarbonylphenylboronic acid (86 mg, 0.48 mmol), [PdACHTUNGTRENNUNG(PPh3)4]
3
3
ꢀ
ꢀ
8.12 (d, J=7.6 Hz, 4H, Ar H), 8.32 (d, J=8.2 Hz, 4H, Ar H), 8.46 (d,
J=8.2 Hz, 4H, Ar H), 8.80 (d, 3J=4.7 Hz, 2H, Hb), 8.82 (s, 2H, Hb),
3
ꢀ
8.90 (s, 2H, Hb), 8.92 ppm (d, 3J=4.7 Hz, 2H, Hb); 13C NMR (125 MHz,
CDCl3, 258C, TMS): d=21.46, 52.37, 118.09, 120.85, 126.80, 127.03,
127.48, 129.12, 129.76, 134.10, 137.09, 138.54, 146.66, 166.89 ppm; UV/Vis
(DMF): lmax (lg e)=420 (4.92), 516 (4.27), 551 (4.08), 581 (3.87), 655 nm
(3.97); HRMS (MS ES+): m/z: calcd for [C50H39N4O4]: 759.2971 [M+H]+
; found 759.2941.
(5.5 mg, 0.005 mmol), and K3PO4 (205 mg, 0.967 mmol) in THF (50 mL)
gave 10 mg (0.013 mmol, 30%) of a purple solid after recrystallization
from CH2Cl2/MeOH. Rf =0.5 (CH2Cl2/n-hexane=1:1, v/v); m.p.>
3008C; 1H NMR (400 MHz, CDCl3, 258C, TMS): d=ꢀ2.76 (s, 2H, NH),
3
4.14 (s, 6H, CH3), 7.79 (d, J=7.6 Hz, 4H, Ar H), 8.24 (d, 3J=8.2 Hz,
ꢀ
4H, Ar H), 8.33 (d, J=8.2 Hz, 4H, Ar H), 8.47 (d, 3J=8.2 Hz, 4H,
3
ꢀ
ꢀ
Ar H), 8.82 (m, 4H, Hb), 8.90 ppm (m, 4H, Hb); 13C NMR (125 MHz,
ꢀ
5,10-Bis(4-cyanophenyl)-15,20-bis(4-methylphenyl)porphyrin (44): By fol-
lowing the general procedure F, compound 29 (30 mg, 0.046 mmol), 4-cy-
anophenyl boronic acid (68 mg, 0.46 mmol), [PdACHTNUTRGNE(UNG PPh3)4] (5.3 mg,
CDCl3, 258C, TMS): d=45.57, 51.99, 118.30, 126.29, 127.44, 129.19,
134.07, 141.47, 146.45, 166.85 ppm; UV/Vis (DMF): lmax (lg e)=418
(4.94), 514 (3.80), 548ACTHNUTRGNE(NUG 3.61), 588 (3.34), 646 nm (3.32); HRMS (MS
0.0046 mmol), and K3PO4 (196 mg, 0.925 mmol) in THF (50 mL) gave
15 mg (0.021 mmol, 47%) of a purple solid after recrystallization from
CH2Cl2/MeOH. Rf =0.34 (CH2Cl2/n-hexane=1:1, v/v); m.p.>3008C;
ES+): m/z: cacld for [C48H35N4O4]: 731.2658 [M+H]+, found 731.2625.
5,10-Bis(4-cyanophenyl)-15,20-diphenylporphyrin (49): By following the
general procedure F, compound 36 (20 mg, 0.032 mmol), 4-cyanophenyl-
boronic acid (47 mg, 0.32 mol), [PdACHTNUGTRNEUNG(PPh3)4] (3.7 mg, 0.003 mmol), and
K3PO4 (136 mg, 0.644 mmol) in THF (50 mL) gave 6 mg (0.009 mmol,
29%) of a purple solid after recrystallization from CH2Cl2/MeOH. Rf =
0.3 (CH2Cl2/n-hexane=1:1, v/v); m.p.>3008C; 1H NMR (400 MHz,
1H NMR (400 MHz, CDCl3, 258C, TMS): d=ꢀ2.79 (s, 2H, NH), 2.74 (s,
3
ꢀ
ꢀ
6H, CH3), 7.60 (d, J=8.2 Hz, 4H, Ar H), 8.10 (m, 8H, Ar H), 8.36 (d,
J=8.2 Hz, 4H, Ar H), 8.75 (d, 3J=4.7 Hz, 2H, Hb), 8.78 (s, 2H, Hb),
3
ꢀ
8.92 (s, 2H, Hb), 8.95 ppm (d, 3J=4.7 Hz, 2H, Hb); 13C NMR (125 MHz,
CDCl3, 258C, TMS): d=21.10, 111.51, 118.57, 121.13, 130.13, 134.29,
137.11, 137.28, 138.30, 146.55 , ppm; UV/Vis (DMF): lmax (lg e)=420
(4.94), 515 (3.79), 551 (3.62), 584 (3.44), 655 nm (3.68); HRMS (MS
ES+): m/z: calcd for [C48H33N6]: 693.2767 [M+H]+, found 693.2734.
ꢀ
CDCl3, 258C, TMS): d=ꢀ2.80 (s, 2H, NH), 7.80 (m, 4H, Ar H), 8.11 (d,
3
3
J=7.6 Hz, 4H, Ar H), 8.23 (d, J=7.6 Hz, 4H, Ar H), 8.37 (d, 3J=
ꢀ
ꢀ
3
ꢀ
8.2 Hz, 4H, Ar H), 8.76 (d, J=4.7 Hz, 2H, Hb), 8.80 (s, 2H, Hb), 8.90 (s,
13570
ꢃ 2011 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Chem. Eur. J. 2011, 17, 13562 – 13573